Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.630
-0.060 (-3.55%)
At close: Mar 13, 2026, 4:00 PM EDT
1.650
+0.020 (1.23%)
After-hours: Mar 13, 2026, 7:32 PM EDT

Coherus Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
88.88125.99102.8963.55417.2
Short-Term Investments
83.25-14.86128.13-
Cash & Short-Term Investments
172.13125.99117.75191.68417.2
Cash Growth
36.62%7.00%-38.57%-54.05%-22.91%
Accounts Receivable
18.42122.33260.52109.96123.02
Inventory
3.174.2162.6138.7937.64
Other Current Assets
12.9989.0634.7640.824.46
Total Current Assets
206.71341.58475.63381.23602.32
Net Property, Plant & Equipment
1.352.585.128.757.81
Other Intangible Assets
46.2453.6571.675.933.56
Goodwill
----3.56
Other Long-Term Assets
4.0550.7377.1884.9365.64
Total Assets
258.34448.53629.6480.85679.33
Accounts Payable
9.9228.4635.2211.5316.16
Accrued Expenses
130.47254.53296.55127.17149.17
Total Current Liabilities
140.39282.98331.77138.69165.33
Long-Term Debt
37.05264.93473.37471.06408.28
Long-Term Leases
1.463.295.335.057.25
Other Long-Term Liabilities
18.4429.3312.563.470.75
Total Long-Term Liabilities
56.94297.54491.26479.57416.28
Total Liabilities
197.33580.52823.03618.27581.61
Common Stock
0.010.010.010.010.01
Additional Paid-in Capital
1,4441,4191,3861,2041,148
Accumulated Other Comprehensive Income
-0.2-0.28-0.25-0.25-0.27
Retained Earnings
-1,383-1,551-1,580-1,342-1,050
Shareholders' Equity
61.01-131.99-193.43-137.4297.73
Total Liabilities & Equity
258.34448.53629.6480.85679.33
Total Debt
38.51268.21478.7476.1415.53
Net Cash (Debt)
133.62-142.23-360.95-284.421.66
Net Cash Growth
-----98.69%
Net Cash Per Share
1.14-1.24-3.83-3.660.02
Book Value
61.01-131.99-193.43-137.4297.73
Book Value Per Share
0.52-1.15-2.05-1.771.30
Tangible Book Value
14.78-185.64-265.1-143.3590.6
Tangible Book Value Per Share
0.13-1.62-2.82-1.851.20
Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q